Arax Advisory Partners’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
Arax Advisory Partners's DFTX Position: Q3 2026 in Review
Arax Advisory Partners increased its Definium Therapeutics (DFTX) stake by 182% in Q3 2026, buying an estimated $60.9K and bringing the position to 2,239 shares worth $85.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2932.
Arax Advisory Partners first reported a position in DFTX in Q2 2021 and has held it in 18 quarters since. 354 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.
- Arax Advisory Partners held 2,239 shares of Definium Therapeutics worth $85.2K as of Q3 2026.
- Arax Advisory Partners bought 1,446 Definium Therapeutics shares in Q3 2026, an estimated $60.9K.
- Definium Therapeutics made up ﹤0.01% of Arax Advisory Partners's portfolio in Q3 2026, its #2932 holding.
- Arax Advisory Partners first reported a position in Definium Therapeutics in Q2 2021 and has held it in 18 quarters since.
- 354 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.
Based on Arax Advisory Partners's 13F filing for Q3 2026, filed 12 Nov 2026.